Completed NA INTERVENTIONAL 2-arm NCT03940963

Study of AxoGuard® Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma Pain (REPOSE)

A Multicenter, Prospective, Randomized and Subject Blinded Comparative Study of AxoGuard® Nerve Cap and Neurectomy for the Treatment of Symptomatic Neuroma and Prevention of Recurrent End-Neuroma Pain

Sponsor: Axogen Corporation

Conditions Chronic Nerve Pain Morton's Neuroma Symptomatic Neuroma

Interventions AxoGuard® Nerve Cap Standard Neurectomy

Updated 14 times since 2019 Last updated: Dec 17, 2024 Started: Oct 10, 2018 Primary completion: Jul 17, 2023 Completion: Jul 17, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Chronic Nerve Pain and Morton's Neuroma, this trial is completed. The trial is conducted by Axogen Corporation and has accumulated 14 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

14 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Feb 2025 — Sep 2025 [monthly]

Completed NA
Oct 2024 — Feb 2025 [monthly]

Completed NA
Sep 2024 — Oct 2024 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA

▶ Show 9 earlier versions

Aug 2023 — Jul 2024 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Apr 2023 — Aug 2023 [monthly]

Active Not Recruiting NA
Sep 2022 — Apr 2023 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Jun 2022 — Sep 2022 [monthly]

Recruiting NA
Jan 2021 — Jun 2022 [monthly]

Recruiting NA
Sep 2020 — Jan 2021 [monthly]

Recruiting NA
Feb 2020 — Sep 2020 [monthly]

Recruiting NA
Oct 2019 — Feb 2020 [monthly]

Recruiting NA
Jun 2019 — Oct 2019 [monthly]

Recruiting NA

First recorded

Oct 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Axogen Corporation

Data source: Axogen Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Austin, United States , Columbus, United States , Denton, United States , Fort Worth, United States , Los Angeles, United States , O'Fallon, United States , Rockford, United States , Roswell, United States , Saint Augustine, United States , Springfield, United States and 1 more location